Purigen Biosystems nabs $26.4 mln Series B
Pleasanton, California-based Purigen Biosystems Inc, a provider of next-generation technologies for extracting, enriching, and quantifying nucleic acids from biological samples, has secured $26.4 million in Series B financing. Agilent Technologies led the round with participation from other backers that included Cota Capital, 5AM Ventures and Roche Venture Fund.
12 June 2019•1 min read
